As Novartis rejuvenates its pipeline with products like iptacopan and currency exchange rates stabilize, expect stronger revenue growth in the medium term for the company.Īnd over five years or more, Novartis can deliver excellent total returns, especially for investors who opt for automatic dividend reinvestment. Last year, it reported positive results from a phase 3 clinical trial for this medicine, which targets, among other things, a rare blood disease with a significant unmet need called paroxysmal nocturnal hemoglobinuria.

One of the company's key candidates is iptacopan. Year over year in constant currency, Novartis' top line increased by a decent 4% and adjusted earnings per share of $6.12 increased by 6%. However, the company's net sales declined by 2% year over year to $50.5 billion, a result it owed to unfavorable currency exchange dynamics. Novartis had 11 other products with more than $1 billion in sales last year. Kisqali and Kesimpta saw their revenues increase by 31% and 194% year over year to $1.2 billion and $1.1 billion, respectively. In 2022, sales of Entresto soared by 31% year over year to $4.7 billion. Some of the company's biggest growth drivers include heart-failure medicine Entresto, cancer drug Kisqali, and multiple sclerosis treatment Kesimpta. A blue-chip stock with an attractive dividendīased in Switzerland, Novartis ( NVS 1.10%) is a biotech with a long list of products. Following are two companies in the biotech industry that seem to have what it takes. Let's address the second problem: finding quality stocks that can help make an investor richer over a sufficiently long period - say, five years or more.

The tendency to panic-sell during a bear market is strong, and with hundreds of options, it can sometimes be challenging to separate the quality stocks from the rest of the pack. But in practice, it isn't always easy to pull that off. All that's needed are time, the right investments, and the patience to hold shares of companies even during downturns.

Growing one's wealth in the stock market is simple, at least in theory.

Pinterest artwork